0000899243-18-031698.txt : 20181226 0000899243-18-031698.hdr.sgml : 20181226 20181226160606 ACCESSION NUMBER: 0000899243-18-031698 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181222 FILED AS OF DATE: 20181226 DATE AS OF CHANGE: 20181226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ross Leonard S CENTRAL INDEX KEY: 0001458753 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 181252751 MAIL ADDRESS: STREET 1: C/O PSIVIDA CORP STREET 2: 400 PLEASANT STREET CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-22 0 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001458753 Ross Leonard S C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 0 1 0 0 See Remarks Common Stock 2018-12-22 4 M 0 62892 A 94709 D Common Stock 2018-12-22 4 F 0 18522 1.65 D 76187 D Restricted stock units 2018-12-22 4 M 0 62892 0.00 D Common Stock 62892 0 D Restricted stock units convert into common stock on a one-for-one basis. No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units. Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on December 21, 2018. On December 22, 2017, the reporting person was granted 62,892 restricted stock units, vesting in full on the first anniversary of the grant date. Vice President of Finance and Chief Accounting Officer /s/ John Mercer, Attorney-in-Fact 2018-12-26